Humatica’s new whitepaper on Buy & Build. Download now
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
How to profit from dynamic markets. Is your organization ready for it? Humatica’s Andros Payne was recently interviewed on the new frontier of behavior-centric business…Read more
Excess liquidity has flooded private markets and reduced the number of easy targets in private equity. Investors are now competing for ever smaller arbitrage opportunities…Read more